Analysis Theralink Technologies Inc. (THER)
5/26/2024
Analysis of Theralink Technologies Inc. (THER)
Theralink Technologies Inc. is showing relatively stable price levels around 0.00070. The RSI indicator is around 45.29, indicating a neutral sentiment in the market. The MACD indicator is slightly negative, with the MACD line below the signal line, suggesting a potential bearish trend.Looking at the moving averages, the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are all relatively close to each other, indicating a consolidation phase in the stock price.
Overall, Theralink Technologies Inc. seems to be trading in a tight range with no significant price movements recently. Traders and investors may want to wait for a clearer trend to emerge before making any trading decisions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous results, ending on February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at this time. The results from August 1, 2024, showed an EPS estimate of 1.33.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits for a particular company.In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31% and the company's fiscal year ends on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.44.
Moving on to stock statistics, the company has a short ratio of 1.66, with 15.31 billion float shares and 94.31 million shares shorted. The stock has an average 10-day volume of 52.90 million and an average 90-day volume of 62.82 million. The stock price summary includes a beta of 1.264, a 50-day moving average of $173.69, and a 200-day moving average of $180.79. The 52-week range is between $164.08 and $199.62.
Valuation metrics show a PEG ratio of 26.21, forward PE of 26.21, trailing PE of 29.43, and an enterprise value of $2.95 trillion. The price to book ratio is 39.18, price to sales ratio is 7.62, enterprise to EBITDA ratio is 22.75, and enterprise to revenue ratio is 7.73. The market capitalization is $2.91 trillion.
Lastly, dividends and splits information indicate a payout ratio of 14.93%, with a dividend date set for May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split factor. The company has a forward annual dividend rate of $1, a 5-year average dividend yield of 0.73%, and a trailing annual dividend yield of 0.51%.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales have been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been relatively stable, with gross profit ranging from around $105 billion to $169 billion.
3. Operating income has also shown a consistent growth trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
4. Net income has been increasing over the years, from $57.4 billion in 2020 to $97 billion in 2023.
5. Earnings per share (EPS) have shown a slight fluctuation but have generally been on an upward trajectory.
6. The company has been able to maintain a healthy EBITDA margin, with EBITDA ranging from $81 billion to $129 billion.
7. Despite an increase in income tax expenses, the company has managed to grow its net income continuously.
8. The company has been effectively managing its operating expenses, with a slight increase in research and development costs over the years.
9. Non-operating interest expenses have been relatively stable, indicating a consistent financial management approach.
10. The number of basic and diluted shares outstanding has remained constant over the years, indicating no significant dilution of shares.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with a slightly higher growth rate expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the next 5 years compared to the past 5 years. The company is projected to experience steady growth in the upcoming quarters and years, indicating a positive outlook according to analyst consensus.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions regarding the future price of the security, with the low end at $164, the high end at $250, and the average forecast at $202.26. The current price of the security is $191.57, which is below the median and average forecast, indicating that there is some optimism among analysts for a potential price increase in the future.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2019 at $90,488,000,000.
6. The company has been investing more in non-current assets over the years, which might indicate long-term growth strategies.
7. The company has been relying more on liabilities rather than shareholders' equity to finance its operations.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. Financing activities show a pattern of common stock repurchase and issuance, as well as long-term debt issuance and payments.
5. Investing activities include the sale and purchase of investments, capital expenditures, and other investing activities.
6. The end cash position has also been fluctuating, reaching its highest value in 2020.
7. The company has been paying dividends to common shareholders and engaging in stock-based compensation.
8. Overall, the company's cash flow statement reflects a mix of operational, financing, and investing activities that impact its financial health and liquidity.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two years. The average estimates are showing an increase compared to the year-ago EPS figures, indicating potential growth in earnings for the company.
MACD of THER
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
